Medical Weight Loss for Wauwatosa, Wisconsin Residents
Wauwatosa, Wisconsin residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Wauwatosa through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Wauwatosa Residents Choose New Hope Weight Loss
Wauwatosa patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Wisconsin and beyond since 2020.
Wauwatosa patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
In Wauwatosa, Wisconsin, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Wauwatosa and the western edge of the Milwaukee metro area. Whether you are starting your first GLP-1 program or switching from a brand medication, your Wauwatosa treatment plan is built around your health history and goals.
Whether you live in central Wauwatosa or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Wauwatosa
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Wauwatosa
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Wauwatosa address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Wauwatosa
Does New Hope Weight Loss treat patients in Wauwatosa?
Yes. Although the clinic is in Costa Mesa, California, we treat Wauwatosa, Wisconsin residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Wauwatosa?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Wauwatosa address in cold-pack packaging.
What do Wauwatosa patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Wauwatosa do you serve?
We serve patients from across Wauwatosa by telehealth, including Wauwatosa and the western edge of the Milwaukee metro area.
How is medication shipped to Wauwatosa patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Wauwatosa address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Wauwatosa, Wisconsin by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.